News
- 08/02/2012Bayer UK and Ireland appoints new chief financial officer
- 08/02/2012Roche's pertuzumab fast-tracked by FDA for breast cancer
- 08/02/2012NICE to help develop local drug formularies
- 08/02/2012AZ’s UK research job losses ‘bad news’ for country’s industry say unions
- 08/02/2012Pharma 'struggling to prove value' as healthcare budgets tighten
- 01/02/2012ProTrials expands European footprint with UK subsidiary
- 01/02/2012Cambridge University joins Lilly’s open-source discovery platform
- 01/02/2012Pfizer's Mark Brincat joins Exco InTouch to lead its mHealth strategy
- 01/02/2012Pfizer in talks to sell Kent, UK research facility
- 01/02/2012Takeda to cut 2,800 jobs in Europe and US
- 01/02/2012Savient Pharmaceuticals appoints David Veitch to lead European operations
- 30/01/2012Amgen to buy German biotech Micromet for $1.16bn
- 30/01/2012Horizon Discovery appoints Eric Rhodes as chief technical officer
- 26/01/2012Watson buys Australian generics maker
- 26/01/2012Astellas Pharma Europe appoints Mike Crooks to lead its UK operations
- 26/01/2012Prosonix Appoints Rob Crocker as its First Head of Regulatory Affairs
- 18/01/2012SkyePharma to cut its Swiss workforce by 20 per cent
- 18/01/2012Former ABPI head Richard Barker joins Aegate as senior adviser
- 18/01/2012Gilead now has 95% of Pharmasset shares
- 17/01/2012Allergan to create 200 Mayo jobs
From the research we have conducted, it is clear there is a gap in the
market for an organization which understands the sector, particularly with
the increased attention being directed at Boards through corporate governance
issues. Bioscience NEDs aims to address this need through its access to an
impressive pool of talent who understand the challenges and issues of life
science companies and have the appetite to really make a difference.
Carolyn Douthwaite, MD
